These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9184376)

  • 1. Identification of a Kb-restricted CTL epitope of beta-galactosidase: potential use in development of immunization protocols for "self" antigens.
    Overwijk WW; Surman DR; Tsung K; Restifo NP
    Methods; 1997 Jun; 12(2):117-23. PubMed ID: 9184376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-2 enhances the function of recombinant poxvirus-based vaccines in the treatment of established pulmonary metastases.
    Bronte V; Tsung K; Rao JB; Chen PW; Wang M; Rosenberg SA; Restifo NP
    J Immunol; 1995 May; 154(10):5282-92. PubMed ID: 7730632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumor activity of cytotoxic T lymphocytes elicited with recombinant and synthetic forms of a model tumor-associated antigen.
    Wang M; Chen PW; Bronte V; Rosenberg SA; Restifo NP
    J Immunother Emphasis Tumor Immunol; 1995 Oct; 18(3):139-46. PubMed ID: 8770769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine.
    Bronte V; Carroll MW; Goletz TJ; Wang M; Overwijk WW; Marincola F; Rosenberg SA; Moss B; Restifo NP
    Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3183-8. PubMed ID: 9096367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of tumoricidal cytotoxic T lymphocytes from healthy donors after in vitro stimulation with a replication-incompetent vaccinia virus encoding MART-1/Melan-A 27-35 epitope.
    Zajac P; Oertli D; Spagnoli GC; Noppen C; Schaefer C; Heberer M; Marti WR
    Int J Cancer; 1997 May; 71(3):491-6. PubMed ID: 9139889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening and Identification of an H-2K
    Ma RX; Cheng LF; Ying QK; Liu RR; Ma TJ; Zhang XX; Liu ZY; Zhang L; Ye W; Zhang FL; Xu ZK; Wang F; Wu XA
    Front Cell Infect Microbiol; 2016; 6():151. PubMed ID: 27933274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of a human agonist cytotoxic T-lymphocyte epitope of human prostate-specific antigen.
    Terasawa H; Tsang KY; Gulley J; Arlen P; Schlom J
    Clin Cancer Res; 2002 Jan; 8(1):41-53. PubMed ID: 11801539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of gene-modified (IL-7, IL-4, and B7) tumor cell vaccines on tumor antigen presentation.
    Cayeux S; Richter G; Noffz G; Dörken B; Blankenstein T
    J Immunol; 1997 Mar; 158(6):2834-41. PubMed ID: 9058819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases.
    Specht JM; Wang G; Do MT; Lam JS; Royal RE; Reeves ME; Rosenberg SA; Hwu P
    J Exp Med; 1997 Oct; 186(8):1213-21. PubMed ID: 9334360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector.
    Juillard V; Villefroy P; Godfrin D; Pavirani A; Venet A; Guillet JG
    Eur J Immunol; 1995 Dec; 25(12):3467-73. PubMed ID: 8566039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo expansion of the residual tumor antigen-specific CD8+ T lymphocytes that survive negative selection in simian virus 40 T-antigen-transgenic mice.
    Schell TD
    J Virol; 2004 Feb; 78(4):1751-62. PubMed ID: 14747540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An endoplasmic reticulum-targeting signal sequence enhances the immunogenicity of an immunorecessive simian virus 40 large T antigen cytotoxic T-lymphocyte epitope.
    Fu TM; Mylin LM; Schell TD; Bacik I; Russ G; Yewdell JW; Bennink JR; Tevethia SS
    J Virol; 1998 Feb; 72(2):1469-81. PubMed ID: 9445050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with human HER-2/neu (435-443) CTL peptide induces effective antitumor immunity against HER-2/neu-expressing tumor cells in vivo.
    Gritzapis AD; Mahaira LG; Perez SA; Cacoullos NT; Papamichail M; Baxevanis CN
    Cancer Res; 2006 May; 66(10):5452-60. PubMed ID: 16707474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid functional exhaustion and deletion of CTL following immunization with recombinant adenovirus.
    Krebs P; Scandella E; Odermatt B; Ludewig B
    J Immunol; 2005 Apr; 174(8):4559-66. PubMed ID: 15814677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rotavirus-specific cytotoxic T lymphocytes recognize overlapping epitopes in the amino-terminal region of the VP7 glycoprotein.
    Buesa J; Raga JV; Colomina J; de Souza CO; Muñoz C; Gil MT
    Virology; 1999 May; 257(2):424-37. PubMed ID: 10329553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination.
    Thomson SA; Sherritt MA; Medveczky J; Elliott SL; Moss DJ; Fernando GJ; Brown LE; Suhrbier A
    J Immunol; 1998 Feb; 160(4):1717-23. PubMed ID: 9469429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen-specific tumor vaccine efficacy in vivo against prostate cancer with low class I MHC requires competent class II MHC.
    Neeley YC; McDonagh KT; Overwijk WW; Restifo NP; Sanda MG
    Prostate; 2002 Nov; 53(3):183-91. PubMed ID: 12386918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction and persistence of a cytotoxic T lymphocyte (CTL) response against a herpes simplex virus-specific CTL epitope expressed in a cellular protein.
    Fu TM; Bonneau RH; Epler M; Tevethia MJ; Alam S; Verner K; Tevethia SS
    Virology; 1996 Aug; 222(1):269-74. PubMed ID: 8806508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential loss of cytotoxic T lymphocyte responses to simian virus 40 large T antigen epitopes in T antigen transgenic mice developing osteosarcomas.
    Schell TD; Knowles BB; Tevethia SS
    Cancer Res; 2000 Jun; 60(11):3002-12. PubMed ID: 10850449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of human cytolytic T lymphocyte lines directed against prostate-specific antigen (PSA) employing a PSA oligoepitope peptide.
    Correale P; Walmsley K; Zaremba S; Zhu M; Schlom J; Tsang KY
    J Immunol; 1998 Sep; 161(6):3186-94. PubMed ID: 9743387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.